洽洽食品(002557.SZ):截至3月末累計回購4999.71萬元股份
格隆匯4月1日丨洽洽食品(002557.SZ)公佈,截止2020年3月31日,公司通過股份回購專用證券賬户以集中競價方式回購公司股份184.41萬股,佔公司目前總股本的0.36%,最高成交價為33.05元/股(因相關人員操作失誤,其中6,000股購買價格成交在33.05元每股,其餘成交價格均在33元每股及以下),最低成交價為21.78元/股,成交總金額約為4999.71萬元(不含交易費用),成交均價27.11元/股。
除了上述由於相關人員誤操作購買6,000股成交價格33.05元每股之外,此次回購符合相關法律法規的要求,符合既定的回購方案。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.